Medicare Will Pay $50K For Your Heart Attack. It Should Pay $100 To Prevent It.
AIThis post was created with the assistance of artificial intelligence (AI).

TL;DR

Before you orderOffer from Amazon

Get workout gear delivered free with Prime

  • Fast, free delivery on millions of items
  • Prime Video, Amazon Music and more included
  • Member-only deals all year
Start your free Prime trial Free trial for eligible customers · Cancel anytime
As an affiliate, we earn on qualifying purchases.

Updated ACC/AHA guidelines issued in March 2026 give coronary artery calcium scans a more central role for adults at borderline or intermediate risk when a prevention-treatment decision is uncertain. The scan can help identify calcified plaque, but the source article’s $100 test and $50,000 heart attack figures are not Medicare coverage figures; it does not establish that Medicare will pay for the scan or specify its reimbursement.

The American College of Cardiology and American Heart Association gave coronary artery calcium scans a central role in their March 2026 prevention guidelines, recommending the test for some adults at borderline or intermediate risk when a decision about preventive treatment remains uncertain. In an October 25 opinion article, physicians Arthur Agatston and Oren Mechanic argued that wider access could help identify coronary plaque before a heart attack, while warning that insurance coverage can limit who gets tested.

A coronary artery calcium (CAC) scan is a short CT scan that detects calcified plaque in the heart’s arteries. Agatston and Mechanic describe it as a roughly 10-minute test costing about $100. Those figures are presented in their opinion article, not as a Medicare fee schedule or guarantee of what an individual patient would pay.

The guidelines recommend considering CAC when conventional risk estimates leave uncertainty about whether to begin preventive treatment, such as a statin. Unlike risk calculators, which estimate the probability of a future event from factors including age, cholesterol, blood pressure, diabetes and smoking, a CAC scan provides evidence of calcified plaque. A score of zero can support a lower risk assessment; a score above 100 may point toward medication and more intensive lifestyle measures, the authors write.

The authors illustrate the approach with a 52-year-old patient, identified by a changed name, whose standard risk calculation suggested low risk. His scan showed a score of 220, which the physicians said indicated substantial plaque for his age and altered their treatment recommendation. This is a case example from the article, not a study establishing how patients generally fare after testing.

At a glance
reportWhen: Guideline update announced March 2026;…
The developmentThe March 2026 ACC/AHA prevention guidelines give coronary artery calcium scanning a central role in certain treatment decisions, prompting two physicians to argue that low-cost prevention deserves wider use.

Prevention Depends on Access

The guideline change may influence how clinicians discuss prevention with patients whose risk falls between clear treatment and clear non-treatment categories. A scan showing plaque can provide information that a risk calculator does not, while a zero score may help some patients and clinicians avoid medication they consider unnecessary. The test is a decision aid, not a treatment or a guarantee that a heart attack will be prevented.

The authors’ central policy argument is about who can access testing. They say clinicians may offer CAC scans mainly to people able to pay out of pocket when insurers do not cover them. If access depends on ability to pay, patients who could benefit from further risk assessment may not receive it. The article’s headline contrasts a roughly $100 scan with a $50,000 heart attack, but it does not provide a cost analysis establishing those amounts as typical or showing that routine scan coverage would save money.

Products Worth Considering

OMRON Complete 2-in-1 Upper Arm Blood Pressure Monitor with EKG

OMRON Complete 2-in-1 Upper Arm Blood Pressure Monitor with EKG

As an affiliate, we earn on qualifying purchases.

From Risk Scores to Imaging

For decades, prevention decisions have relied heavily on calculators that estimate cardiovascular risk from population-level factors. The authors argue that these tools can miss differences between people with similar cholesterol readings, because they do not directly show whether plaque is present. They also point to inherited risk, which they say accounts for roughly half of cardiovascular risk and is not included in the calculators they discuss.

The physicians say CAC evidence accumulated over more than three decades, while the scan played a limited role in national guidance until the March 2026 update. They attribute the delay partly to clinical systems designed around standard risk factors, cautious guideline processes and insurer reimbursement practices. The source is an opinion piece by two physicians, rather than a new clinical trial or a Medicare coverage announcement.

They also describe possible use of artificial intelligence to identify calcification on chest CT scans already taken for other reasons. Such analysis could flag people for a formal prevention assessment, they argue. They say AI-based methods are being used to assess soft plaque as well, but the article does not provide performance data or establish that this approach is recommended in the guidelines.

“The guidelines have finally caught up to the evidence supporting coronary artery calcium scans.”

— Arthur Agatston, MD, and Oren Mechanic, MD, MPH, in their October 25, 2026 opinion article

Coverage and Outcomes Remain Unclear

The article does not say whether Medicare covers CAC scans, what Medicare pays for them, or whether coverage rules changed alongside the guidelines. Its headline should not be read as evidence that Medicare pays $50,000 for every heart attack or would pay $100 for a preventive scan. Actual hospital costs, reimbursements and patient expenses can vary, and the source supplies no billing data to substantiate those amounts as standard rates.

It is also unclear how broadly the updated recommendations will change clinical practice or insurance coverage. The opinion article does not present a new population study quantifying how many heart attacks scans would prevent, the effect on health disparities, or the cost-effectiveness of screening. CAC measures calcified plaque; the article’s discussion of AI detection of soft plaque is a separate developing area and is not shown to have the same evidence base or guideline status.

Guidance Must Reach Clinical Practice

The next practical questions are whether health systems incorporate the updated guidance into prevention discussions and whether insurers, including Medicare, cover scans for patients who meet the recommended circumstances. Patients should discuss individual risk and the potential benefits and limits of testing with a clinician; the guideline does not call for every adult to receive a scan.

Agatston and Mechanic also point to opportunistic review of existing chest CT scans as a possible route to identifying plaque without ordering a separate scan. Wider use would depend on validated methods, clinical follow-up and decisions about reporting and payment. The source article does not identify a specific Medicare policy decision or implementation deadline.

Key Questions

Did Medicare announce that it will pay $100 for a calcium scan?

No such announcement is reported in the source. The roughly $100 cost is the authors’ estimate for the scan, not a confirmed Medicare payment rate or coverage guarantee.

Who may be considered for a CAC scan under the updated guidance?

The March 2026 ACC/AHA guidelines recommend considering CAC for adults at borderline or intermediate risk when it remains uncertain whether to start preventive treatment. The article does not recommend routine scanning for everyone.

What does a CAC score measure?

It detects and measures calcified plaque in the coronary arteries. The score can help inform a risk discussion, but it does not itself treat plaque or guarantee whether someone will have a heart attack.

Does a score of zero mean there is no heart disease?

No. The authors say a score of zero can reclassify risk downward, but it is not described as proof that a person has no cardiovascular risk. A clinician can interpret the result alongside other health factors.

What remains uncertain about AI analysis of chest CT scans?

The authors describe AI as a possible way to identify calcification on scans taken for other reasons and mention work on soft plaque. Their article does not provide accuracy or outcome data showing how well these tools perform or establish them as a standard recommendation.

Source: rss

Wellness content on this site is informational and not a substitute for professional medical guidance.
You May Also Like

RFK Jr. Assures Vaccine Skeptics They Have A ‘Friend At The White House’

RFK Jr. publicly reassures vaccine skeptics of support from the Biden administration, amid rising interest and debate over vaccine policies and skepticism.

Children Treatment Centre Surges In Global Coverage

The Children Treatment Centre sees a significant increase in international media mentions, highlighting growing global attention to pediatric healthcare initiatives.

FDA recalls millions of cooling eye drops over sterility concerns

The FDA has issued a recall of over 500,000 bottles of Rohto cooling eye drops due to potential sterility issues, prompting safety warnings for consumers.